drugset / Trial / NCT02973893
Study of VF001-DP in Patients With Chronic Venous Leg Ulcers
Phase 2
Unknown
156 enrolled
Factor Therapeutics Ltd.
ALMAC Clinical Services · collabARANZ Medical · collabParexel · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if VF001-DP improves wound healing in chronic venous leg ulcers compared to standard care only.
Timeline
- Start
- 2016-11
- Primary completion
- 2018-11
- Completion
- 2019-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VF001-DP | Protein / enzyme biologic | 14 ug | — |
| Subject | VF001-DP | Protein / enzyme biologic | 140 ug | — |